The Connective Tissue Disorders Panel is a comprehensive diagnostic tool designed to evaluate immune markers associated with autoimmune conditions such as rheumatoid arthritis, lupus, and scleroderma. Utilizing cutting-edge immunofluorescence and microarray technology, this panel helps detect early immune dysregulation and supports the clinical assessment of connective tissue-related disorders, guiding personalized management strategies.